Atea Pharmaceuticals (AVIR) Accumulated Depreciation (2020 - 2021)
Atea Pharmaceuticals (AVIR) has 2 years of Accumulated Depreciation data on record, last reported at $161000.0 in Q4 2021.
- For Q4 2021, Accumulated Depreciation rose 21.97% year-over-year to $161000.0; the TTM value through Dec 2021 reached $161000.0, up 21.97%, while the annual FY2021 figure was $161000.0, 21.97% up from the prior year.
- Accumulated Depreciation reached $161000.0 in Q4 2021 per AVIR's latest filing, up from $132000.0 in the prior quarter.
- Across five years, Accumulated Depreciation topped out at $161000.0 in Q4 2021 and bottomed at $126000.0 in Q3 2020.